Differences in the ferrihemoglobin-forming capabilities and carcinogenicities between monocyclic and polycyclic N-acylarylamines and their derivatives.
D000081:Acetamides / Q000633:toxicity; D000083:Acetanilides / Q000633:toxicity*; D000611:Aminobiphenyl Compounds / Q000633:toxicity; D000814:Aniline Compounds / Q000633:toxicity; D000818:Animals; D002273:Carcinogens / Q000633:toxicity*; D002415:Cats; D004285:Dogs; D005449:Fluorenes / Q000633:toxicity; D006454:Hemoglobins / Q000378:metabolism; D008706:Methemoglobin / Q000096:biosynthesis*; D010084:Oxidation-Reduction; D013329:Structure-Activity Relationship
D000081:Acetamides; D000083:Acetanilides; D000611:Aminobiphenyl Compounds; D000814:Aniline Compounds; D002273:Carcinogens; D005449:Fluorenes; D006454:Hemoglobins; C012177:2-aminofluorene; D008706:Methemoglobin